Smith & Nephew plc (SNN)

USD 24.89

(-2.16%)

Operating Income Summary of Smith & Nephew plc

  • Smith & Nephew plc's latest annual operating income in 2023 was 425 Million USD , up 40.9% from previous year.
  • Smith & Nephew plc's latest quarterly operating income in 2024 Q2 was 328 Million USD , down 0.0% from previous quarter.
  • Smith & Nephew plc reported an annual operating income of 665 Million USD in 2022, down -6.6% from previous year.
  • Smith & Nephew plc reported an annual operating income of 712 Million USD in 2021, up 64.43% from previous year.
  • Smith & Nephew plc reported a quarterly operating income of 315 Million USD for 2023 Q2, down 0.0% from previous quarter.
  • Smith & Nephew plc reported a quarterly operating income of 444.43 Million USD for 2023 Q4, down 0.0% from previous quarter.

Annual Operating Income Chart of Smith & Nephew plc (2023 - 1989)

Historical Annual Operating Income of Smith & Nephew plc (2023 - 1989)

Year Operating Income Operating Income Growth
2023 425 Million USD 40.9%
2022 665 Million USD -6.6%
2021 712 Million USD 64.43%
2020 433 Million USD -55.86%
2019 981 Million USD 0.51%
2018 976 Million USD 11.54%
2017 875 Million USD -4.06%
2016 912 Million USD 22.42%
2015 745 Million USD -20.06%
2014 932 Million USD 4.95%
2013 888 Million USD 4.96%
2012 846 Million USD -1.86%
2011 862 Million USD -6.3%
2010 920 Million USD 27.25%
2009 723 Million USD 14.76%
2008 630 Million USD 27.79%
2007 493 Million USD -8.19%
2006 537 Million USD 27.25%
2005 422 Million USD 33.1%
2004 317.05 Million USD -1.25%
2003 321.07 Million USD 32.27%
2002 242.73 Million USD 7.47%
2001 225.85 Million USD 5.16%
2000 214.78 Million USD 20.37%
1999 178.43 Million USD -15.02%
1998 209.97 Million USD -22.03%
1997 269.29 Million USD -13.55%
1996 311.5 Million USD 23.07%
1995 253.1 Million USD 17.66%
1994 215.12 Million USD -9.84%
1993 238.59 Million USD 11.02%
1992 214.91 Million USD -14.92%
1991 252.61 Million USD -25.55%
1990 339.3 Million USD 22.01%
1989 278.08 Million USD 6.21%

Peer Operating Income Comparison of Smith & Nephew plc

Name Operating Income Operating Income Difference
Abbott Laboratories 6.47 Billion USD 93.439%
Allurion Technologies Inc. -78.07 Million USD 644.327%
Artivion, Inc. 5.74 Million USD -7301.602%
Avanos Medical, Inc. 4.2 Million USD -10019.048%
Butterfly Network, Inc. -145.61 Million USD 391.876%
Butterfly Network, Inc. -145.61 Million USD 391.876%
Bio-Rad Laboratories, Inc. 383.79 Million USD -10.736%
Boston Scientific Corporation 2.34 Billion USD 81.861%
Perspective Therapeutics, Inc. -15.18 Million USD 2899.368%
CONMED Corporation 130.78 Million USD -224.958%
Edwards Lifesciences Corporation 1.53 Billion USD 72.296%
Paragon 28, Inc. -37.3 Million USD 1239.135%
Glaukos Corporation -128.7 Million USD 430.225%
Globus Medical, Inc. 133.14 Million USD -219.208%
Inspire Medical Systems, Inc. -40.27 Million USD 1155.35%
Integer Holdings Corporation 167.33 Million USD -153.989%
Medtronic plc 5.14 Billion USD 91.738%
Nevro Corp. -99.3 Million USD 527.961%
Owlet, Inc. -28.63 Million USD 1584.353%
Penumbra, Inc. 73.55 Million USD -477.83%
Vicarious Surgical Inc. -80.66 Million USD 626.864%
Sonendo, Inc. -57.74 Million USD 836.02%
STERIS plc 836.11 Million USD 49.17%
Stryker Corporation 3.88 Billion USD 89.069%
Vapotherm, Inc. -39.08 Million USD 1187.513%
Zimmer Biomet Holdings, Inc. 1.27 Billion USD 66.737%